---
$id: https://graph.org.ai/products/commodity/51111659
$type: Product
source: UNSPSC
code: "51111659"
title: "Topotecan"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Topotecan

**UNSPSC Code**: 51111659
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a camptothecin analogue, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7M7YKX2N15. European Medicines Agency schedules Topotecan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11191MIG. Topotecan generally arises in the molecular formula C23H23N3O5. The term TOPOTECAN is an International Non-Proprietary Name or INN. TOPOTECAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule topotecan under HS 29399900 and SITC 54149. As of Q4 2014, TOPOTECAN remains the US FDA Preferred Term for this commodity. Topotecan bears US NLM identifiers UMLS ID C0146224 and NCI Concept Code C1413. SMILES: O1CC2C(C(O)(CC)C1=O)CC1N(CC3C1NC1C(C3)C(CN(C)C)C(O)CC1)C2=O.

